Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140023
Status:
COMPLETED
Last Update Posted:
2011-05-10
First Post:
2005-08-29
Brief Title:
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multi-center Open Label Study to Evaluate the Efficacy and Safety of Azithromycin Microspheres in Subjects Identified as Having Low Risk Community Acquired Pneumonia CAP
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will assess the clinical efficacy at Day 14-21 Test of Cure 14-21 days after starting the study drug those subjects from whom a baseline pathogen is identified will also be assessed for bacteriologic response All subjects who receive 1 dose of study medication will be assessed for safety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None